Based on effective route design and strong process optimization capabilities, the problems of chiral isomer impurities of drugs with similar physicochemical properties caused by similar structures are solved from the source.

The team is proficient in traditional chiral separation technology, asymmetric synthesis technology, new chiral catalysis technology, chiral separation and purification technology, and effectively realizes the pharmaceutical research and development needs related to chiral drugs, such as impurities control, structural identification, and quality research.

The chiral drug development process is equipped with a variety of impurity sample acquisition methods, accurate quality control strategies, comprehensive analysis method development capabilities, and perfect software and hardware analysis facilities, from small-scale research to production scale-up, fully meeting the requirements of product industrialization.